FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076331410> ?p ?o ?g. }

• W2076331410 endingPage "386" @default.
• W2076331410 startingPage "376" @default.
• W2076331410 abstract "Summary Although the potent vasodilating effect of flosequinan is well characterised, the positive inotropic action reported is more varied and less well understood. We examined the contractile and electrophysiologic effects of flosequinan and its metabolite. BTS 53554, in cardiomyocytes from either adult male Sprague-Dawley rats (200–250 g) or New-Zealand White rabbits (2–2.5 kg) and compared the effects with those of sulmazole and enoximone [selective phosphodiesterase (PDE) III inhibitors], Ro 20–1724 and rolipram (selective PDE IV inhibitors) and 3-isobutyl-l-methylxanthine (IBMX, nonselective PDE inhibitor). Flosequinan and BTS 53554 had positive contractile effects (p < 0.05) in both rat and rabbit ventricular cardiomyocytes only at the maximum concentration (10-3M). Differences were noted between species, however. Flosequinan 10-3M had a greater contractile effect than BTS 53554 (10-3M) in rabbit cardiomyocytes, but not in rat cardiomyocytes. We studied the interaction of flosequinan or the metabolite with other PDE inhibitors in rat cardiomyocytes. Contractile amplitudes were not significantly different with equimolar concentrations (3 × 10 4M) of Ro 20–1724, flosequinan, or BTS 53554 alone (15 ± 6. 18 ± 4. and 32 ± 10%, respectively, greater than the mean basal dL value of 7.38 ± 0.12%, mean ± SE error). However, the combinations of Ro 20–1724 with flosequinan and Ro 20–1724 with BTS 53554 produced synergistic responses: 71 ± 10 and 72 ± 14%, respectively, greater than the mean basal dL value (p < 0.05). In contrast, the combinations of either flosequinan or BTS 53554 with IBMX or sulmazole produced no further increase in contractile amplitude. Neither flosequinan nor BTS 53554 produced any detectable increase in cyclic AMP, whereas significant increases were noted with Ro 20–1724, IBMX, and sulmazole (p < 0.05) in rat cardiomyocytes. Flosequinan increased beating frequency in rat isolated right auricles concentration dependently and was significant over the concentration range of 10-5-3 × 10-4M; flosequinan 3 × 10 4M maximally increased the mean frequency of beating by 35% of the predrug value (255 ± 15 beats/min). Flosequinan had no effect on resting membrane potential, amplitude, or maximum upstroke velocity in rat isolated left ventricular (LV) papillary muscle, but at the maximum concentration (10 3M), flosequinan decreased action potential duration (APD) at 10, 50, and 75% of repolarization (p < 0.05). BTS 53554 produced no changes in AP characteristics over the concentration range of 10 5-10-3M. The positive contractile and electrophysiologic effects of flosequinan and its major metabolite. BTS 53554, result from selective inhibition of the PDE III isoenzyme. However, these effects were observed only at increased concentrations and probably have no clinical value. Flosequinan had a more pronounced effect on chronotropy (10-5-3 × 10 4M) than on contractile function, which was influenced significantly only at an increased concentration (10-3M). Potentiation of the response to rolipram, in terms of APD prolongation, may be caused by a novel mechanism of action such as enhanced intracellular release of Ca2+ by flosequinan." @default.
• W2076331410 created "2016-06-24" @default.
• W2076331410 creator A5022597113 @default.
• W2076331410 creator A5031151405 @default.
• W2076331410 creator A5062328963 @default.
• W2076331410 date "1995-03-01" @default.
• W2076331410 modified "2023-09-26" @default.
• W2076331410 title "Actions of the Novel Vasodilator, Flosequinan, in Isolated Ventricular Cardiomyocytes" @default.
• W2076331410 doi "https://doi.org/10.1097/00005344-199503000-00005" @default.
• W2076331410 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7769801" @default.
• W2076331410 hasPublicationYear "1995" @default.
• W2076331410 type Work @default.
• W2076331410 sameAs 2076331410 @default.
• W2076331410 citedByCount "21" @default.
• W2076331410 countsByYear W20763314102014 @default.
• W2076331410 countsByYear W20763314102017 @default.
• W2076331410 countsByYear W20763314102019 @default.
• W2076331410 countsByYear W20763314102023 @default.
• W2076331410 crossrefType "journal-article" @default.
• W2076331410 hasAuthorship W2076331410A5022597113 @default.
• W2076331410 hasAuthorship W2076331410A5031151405 @default.
• W2076331410 hasAuthorship W2076331410A5062328963 @default.
• W2076331410 hasBestOaLocation W20763314101 @default.
• W2076331410 hasConcept C120770815 @default.
• W2076331410 hasConcept C126322002 @default.
• W2076331410 hasConcept C134018914 @default.
• W2076331410 hasConcept C155710745 @default.
• W2076331410 hasConcept C181199279 @default.
• W2076331410 hasConcept C185592680 @default.
• W2076331410 hasConcept C24998067 @default.
• W2076331410 hasConcept C2776766087 @default.
• W2076331410 hasConcept C2776958096 @default.
• W2076331410 hasConcept C2776980637 @default.
• W2076331410 hasConcept C2777477808 @default.
• W2076331410 hasConcept C2778024521 @default.
• W2076331410 hasConcept C2779276759 @default.
• W2076331410 hasConcept C2779306644 @default.
• W2076331410 hasConcept C2779739782 @default.
• W2076331410 hasConcept C2780529135 @default.
• W2076331410 hasConcept C2781298581 @default.
• W2076331410 hasConcept C55493867 @default.
• W2076331410 hasConcept C62826618 @default.
• W2076331410 hasConcept C71924100 @default.
• W2076331410 hasConcept C86803240 @default.
• W2076331410 hasConceptScore W2076331410C120770815 @default.
• W2076331410 hasConceptScore W2076331410C126322002 @default.
• W2076331410 hasConceptScore W2076331410C134018914 @default.
• W2076331410 hasConceptScore W2076331410C155710745 @default.
• W2076331410 hasConceptScore W2076331410C181199279 @default.
• W2076331410 hasConceptScore W2076331410C185592680 @default.
• W2076331410 hasConceptScore W2076331410C24998067 @default.
• W2076331410 hasConceptScore W2076331410C2776766087 @default.
• W2076331410 hasConceptScore W2076331410C2776958096 @default.
• W2076331410 hasConceptScore W2076331410C2776980637 @default.
• W2076331410 hasConceptScore W2076331410C2777477808 @default.
• W2076331410 hasConceptScore W2076331410C2778024521 @default.
• W2076331410 hasConceptScore W2076331410C2779276759 @default.
• W2076331410 hasConceptScore W2076331410C2779306644 @default.
• W2076331410 hasConceptScore W2076331410C2779739782 @default.
• W2076331410 hasConceptScore W2076331410C2780529135 @default.
• W2076331410 hasConceptScore W2076331410C2781298581 @default.
• W2076331410 hasConceptScore W2076331410C55493867 @default.
• W2076331410 hasConceptScore W2076331410C62826618 @default.
• W2076331410 hasConceptScore W2076331410C71924100 @default.
• W2076331410 hasConceptScore W2076331410C86803240 @default.
• W2076331410 hasIssue "3" @default.
• W2076331410 hasLocation W20763314101 @default.
• W2076331410 hasLocation W20763314102 @default.
• W2076331410 hasLocation W20763314103 @default.
• W2076331410 hasOpenAccess W2076331410 @default.
• W2076331410 hasPrimaryLocation W20763314101 @default.
• W2076331410 hasRelatedWork W1981626358 @default.
• W2076331410 hasRelatedWork W1982310992 @default.
• W2076331410 hasRelatedWork W2012348315 @default.
• W2076331410 hasRelatedWork W2015213504 @default.
• W2076331410 hasRelatedWork W2024881120 @default.
• W2076331410 hasRelatedWork W2042836765 @default.
• W2076331410 hasRelatedWork W2065415363 @default.
• W2076331410 hasRelatedWork W2076331410 @default.
• W2076331410 hasRelatedWork W2229042306 @default.
• W2076331410 hasRelatedWork W4243192595 @default.
• W2076331410 hasVolume "25" @default.
• W2076331410 isParatext "false" @default.
• W2076331410 isRetracted "false" @default.
• W2076331410 magId "2076331410" @default.
• W2076331410 workType "article" @default.